Anzeige
Meldung des Tages: Strom schlägt Bitcoin – Die eigentliche Schlacht im Bitcoin-Markt wird auf der Stromrechnung entschieden

Icecure Medical News

Aktie
WKN:  A1W1LG ISIN:  IL0011224156 US-Symbol:  ICCM Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Israel
0,3536 $
-0,0085 $
-2,35%
0,30085 € 21.04.26
Depot/Watchlist
Marktkapitalisierung *
34,19 Mio. €
Streubesitz
52,20%
KGV
-
Index-Zuordnung
-

Icecure Medical News

24.07.25 - PR Newswire
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period PR Newswire
10.07.25 - PR Newswire
IceCure Announces Commencement of Rights Offering
IceCure Announces Commencement of Rights Offering PR Newswire
03.07.25 - PR Newswire
IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025
IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025 PR Newswire
25.06.25 - PR Newswire
IceCure Announces Record Date for Rights Offering for Up to $10 Million
IceCure Announces Record Date for Rights Offering for Up to $10 Million PR Newswire
09.06.25 - PR Newswire
IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes
IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes PR Newswire
28.05.25 - PR Newswire
IceCure Medical Reports First Quarter 2025 Financial Results
IceCure Medical Reports First Quarter 2025 Financial Results PR Newswire
21.05.25 - PR Newswire
IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025
IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 PR Newswire
06.05.25 - PR Newswire
IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation
IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation PR Newswire
30.04.25 - PR Newswire
IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer
IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-​Stage Breast ...
28.04.25 - PR Newswire
IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium
IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium PR Newswire
22.04.25 - PR Newswire
IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation
IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation PR Newswire

Newssuche

Videos

newspaper
20.04.26 -1,96%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »